Logo image of SAN.PA

SANOFI (SAN.PA) Stock Fundamental Analysis

EPA:SAN - FR0000120578 - Common Stock

84.49 EUR
-0.87 (-1.02%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SAN. SAN was compared to 50 industry peers in the Pharmaceuticals industry. SAN scores excellent on profitability, but there are some minor concerns on its financial health. SAN has a decent growth rate and is not valued too expensively. SAN also has an excellent dividend rating. These ratings would make SAN suitable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SAN had positive earnings in the past year.
SAN had a positive operating cash flow in the past year.
SAN had positive earnings in each of the past 5 years.
In the past 5 years SAN always reported a positive cash flow from operatings.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 11.05%, SAN is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
SAN's Return On Equity of 19.73% is fine compared to the rest of the industry. SAN outperforms 68.00% of its industry peers.
With a decent Return On Invested Capital value of 13.84%, SAN is doing good in the industry, outperforming 72.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SAN is significantly below the industry average of 15.89%.
The last Return On Invested Capital (13.84%) for SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SAN's Profit Margin of 20.35% is fine compared to the rest of the industry. SAN outperforms 78.00% of its industry peers.
In the last couple of years the Profit Margin of SAN has grown nicely.
Looking at the Operating Margin, with a value of 23.59%, SAN is in line with its industry, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SAN has grown nicely.
SAN has a Gross Margin (71.70%) which is in line with its industry peers.
SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SAN is creating value.
SAN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for SAN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, SAN has an improved debt to assets ratio.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

SAN has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SAN would need 2.21 years to pay back of all of its debts.
SAN has a Debt to FCF ratio of 2.21. This is amongst the best in the industry. SAN outperforms 84.00% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that SAN is not too dependend on debt financing.
SAN has a better Debt to Equity ratio (0.21) than 76.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.86
WACC7.46%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.27 indicates that SAN should not have too much problems paying its short term obligations.
The Current ratio of SAN (1.27) is comparable to the rest of the industry.
A Quick Ratio of 0.94 indicates that SAN may have some problems paying its short term obligations.
SAN has a Quick ratio of 0.94. This is comparable to the rest of the industry: SAN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The earnings per share for SAN have decreased by -2.20% in the last year.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
The Revenue has been growing slightly by 6.45% in the past year.
Measured over the past years, SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%

3.2 Future

Based on estimates for the next years, SAN will show a small growth in Earnings Per Share. The EPS will grow by 6.38% on average per year.
Based on estimates for the next years, SAN will show a small growth in Revenue. The Revenue will grow by 4.01% on average per year.
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.38%
Revenue Next Year0.18%
Revenue Next 2Y3.45%
Revenue Next 3Y4.32%
Revenue Next 5Y4.01%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.19, the valuation of SAN can be described as reasonable.
78.00% of the companies in the same industry are more expensive than SAN, based on the Price/Earnings ratio.
SAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.08.
A Price/Forward Earnings ratio of 9.69 indicates a reasonable valuation of SAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SAN indicates a somewhat cheap valuation: SAN is cheaper than 78.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.72, SAN is valued rather cheaply.
Industry RankSector Rank
PE 11.19
Fwd PE 9.69
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SAN's Enterprise Value to EBITDA ratio is in line with the industry average.
SAN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 20.46
EV/EBITDA 10.97
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)2.86
PEG (5Y)2.2
EPS Next 2Y6.53%
EPS Next 3Y6.33%

8

5. Dividend

5.1 Amount

SAN has a Yearly Dividend Yield of 4.48%, which is a nice return.
Compared to an average industry Dividend Yield of 2.97, SAN pays a better dividend. On top of this SAN pays more dividend than 86.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.48%

5.2 History

The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

SANOFI

EPA:SAN (8/29/2025, 7:00:00 PM)

84.49

-0.87 (-1.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-24 2025-10-24/bmo
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap206.07B
Analysts80
Price Target109.75 (29.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.48%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-1.82%
PT rev (3m)-7.63%
EPS NQ rev (1m)-4.35%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)-4.12%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)-1.22%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-1.33%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 11.19
Fwd PE 9.69
P/S 3.04
P/FCF 20.46
P/OCF 18.11
P/B 2.94
P/tB 22.17
EV/EBITDA 10.97
EPS(TTM)7.55
EY8.94%
EPS(NY)8.72
Fwd EY10.32%
FCF(TTM)4.13
FCFY4.89%
OCF(TTM)4.67
OCFY5.52%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.86
PEG (5Y)2.2
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.46%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.38%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year0.18%
Revenue Next 2Y3.45%
Revenue Next 3Y4.32%
Revenue Next 5Y4.01%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y9.86%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%